Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 453

The DOI matches its Crossref record; 353 of the 353 references it cites were found in a registry or an index.

The Role of Liver-Derived Insulin-Like Growth Factor-I

Open access
Ohlsson, Claes, Mohan, Subburaman, Sjögren, Klara, Tivesten, Åsa, Isgaard, Jörgen, Isaksson, Olle, Jansson, John-Olov, Svensson, Johan·2009·Endocrine Reviews

Abstract

IGF-I is expressed in virtually every tissue of the body, but with much higher expression in the liver than in any other tissue.Studies using mice with liver-specific IGF-I knockout have demonstrated that liver-derived IGF-I, constituting a major part of circulating IGF-I, is an important endocrine factor involved in a variety of physiological and pathological processes.Detailed studies comparing the impact of liver-derived IGF-I and local bonederived IGF-I demonstrate that both sources of IGF-I can stimulate longitudinal bone growth.We propose here that liver-derived circulating IGF-I and local bone-derived IGF-I to some extent have overlapping growth-promoting effects and might have the capacity to replace each other (ϭ redundancy) in the maintenance of normal longitudinal bone growth.Importantly, and in contrast to the regulation of longitudinal bone growth, locally derived IGF-I cannot replace (ϭ lack of redundancy) liver-derived IGF-I for the regulation of a large number of other parameters including GH secretion, cortical bone mass, kidney size, prostate size, peripheral vascular resistance, spatial memory, sodium retention, insulin sensitivity, liver size, sexually dimorphic liver functions, and progression of some tumors.It is clear that a major role of liver-derived IGF-I is to regulate GH secretion and that some, but not all, of the phenotypes in the liver-specific IGF-I knockout mice are indirect, mediated via the elevated GH levels.All of the described multiple endocrine effects of liver-derived IGF-I should be considered in the development of possible novel treatment strategies aimed at increasing or reducing endocrine IGF-I activity.(Endocrine Reviews 30: 494 -535, 2009) I. Introduction II.Liver-Derived IGF-I and Longitudinal Bone Growth A. Background, including the original somatomedin hypothesis B. Tissue-specific manipulation of IGF-I expression C. Target cells for GH and IGF-I in the growth plate D. Human genetic disorders and skeletal growth E. Mechanism of action for GH and IGF-I in the regulation of bone growth-an update III.Effects of Liver-Derived vs. Locally Produced IGF-I on Bone Mass A. In vivo and in vitro studies on IGF-I expression and action in bone B. Transgenic overexpression in bone C. Conditional knockout in bone D. Liver-derived IGF-I and bone mass IV.Liver-Derived IGF-I and GH Secretion A. Pulsatile GH secretion B. Negative feedback of liver-derived IGF-I on GH secretion C. Liver-derived IGF-I and sexually dimorphic effects of GH D. Human studies V.The Role of Liver-Derived IGF-I for Metabolism and Body Composition A. Carbohydrate metabolism B. Fat mass C. Lipid metabolism VI.Liver-Derived IGF-I and Other Tissues A. Brain B. Cardiovascular system C. Kidney D. Liver E. Prostate VII.Clinical Implications A. Indications for the use of IGF-I and adverse effects B. Potential indications for combined GH and IGF-I treatment C. Diabetes mellitus D. Other potential future indications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2009-0010

Cites

353 of 353 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 353 references

Cited by

See all 453

Metadata

Authors
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J.
Venue
Endocrine Reviews
Published
2009-07-09
Volume
30
Issue
5
Pages
494-535
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2127573768
Cited by
453
References
353
FWCI
21.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Liver-Derived Insulin-Like Growth Factor-I. https://app.cochat.ai/papers/10.1210/er.2009-0010
The paper
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009). The Role of Liver-Derived Insulin-Like Growth Factor-I. Endocrine Reviews. https://doi.org/10.1210/er.2009-0010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.